General Replicel/Shiseido News

[young]

Promisses and more promisses. In 2018 they are going to get data. So, if this works, I think that would be in the market no before 2030.
I already throw the towel

No need for that yet. Read the whole thing first.

[SebaURU]

I've already done

[Sean]

Just received an email from Replicel with CEO’s message:

“We now have a well-capitalized, very motivated partner developing and commercializing products with us in greater China, we anticipate hearing sometime soon about the clinical results from the Shiseido-sponsored hair loss study in Japan, and we are now months away from having commercial-grade units of the dermal injector in our hands. ”

[mrclean]

I just read a statement from the CEO and the timeline seemed to indicate 15 to 18 months to see if Shiseido will launch RCH-01
Remember it was going to be available at the end of this year! I give up...it is hopeless.

[SebaURU]

I just read a statement from the CEO and the timeline seemed to indicate 15 to 18 months to see if Shiseido will launch RCH-01
Remember it was going to be available at the end of this year! I give up...it is hopeless.

The problem is not the 15 or 18 month, the problem is that we don´t know if it is going to work this treatment. Another problem is that is going to be launched in Japan. What about the people we live in SouthAmerica?

[mrclean]

The problem is not the 15 or 18 month, the problem is that we don´t know if it is going to work this treatment. Another problem is that is going to be launched in Japan. What about the people we live in SouthAmerica?

The problem is the 15 to 18 months. It is always 2 more years away even when promised much sooner.

[SebaURU]

The problem is the 15 to 18 months. It is always 2 more years away even when promised much sooner.

jajaja! It seems that you care more about its launch to the market that the product really works.
Tell me, what happened to the other products that was delayed its release to the market? Did they work? DO NOT!! The same will happen with this one.